BR0309688A - Microemulsões poliméricas - Google Patents

Microemulsões poliméricas

Info

Publication number
BR0309688A
BR0309688A BR0309688-2A BR0309688A BR0309688A BR 0309688 A BR0309688 A BR 0309688A BR 0309688 A BR0309688 A BR 0309688A BR 0309688 A BR0309688 A BR 0309688A
Authority
BR
Brazil
Prior art keywords
liquid
polymeric microemulsions
temperature below
microemulsions
polymeric
Prior art date
Application number
BR0309688-2A
Other languages
English (en)
Inventor
Albertina Maria Eduarda Arien
Marcus Eli Brewster
Aruna Nathan
Joel Rosenblatt
Louisa Myriam Ould-Ouali
Veronique Preat
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR0309688A publication Critical patent/BR0309688A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/46—Polyesters chemically modified by esterification
    • C08G63/48—Polyesters chemically modified by esterification by unsaturated higher fatty oils or their acids; by resin acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/64—Polyesters containing both carboxylic ester groups and carbonate groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/18—Block or graft polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/18—Block or graft polymers
    • C08G64/183—Block or graft polymers containing polyether sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10—Definition of the polymer structure
    • C08G2261/12—Copolymers
    • C08G2261/126—Copolymers block
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/05—Polymer mixtures characterised by other features containing polymer components which can react with one another
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paper (AREA)
  • Centrifugal Separators (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

"MICROEMULSõES POLIMéRICAS". A presente invenção refere-se a novos copolímeros em dibloco auto-emulsificantes e novas composições auto-emulsificantes que compreendem um ingrediente ativo e um copolímero em dibloco, caracterizados pelo fato de que o copolímero em dibloco é líquido a uma temperatura abaixo de 50<198>C e a composição é não-aquosa e líquida a uma temperatura abaixo de 50<198>C.
BR0309688-2A 2002-05-03 2003-04-24 Microemulsões poliméricas BR0309688A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37790102P 2002-05-03 2002-05-03
PCT/EP2003/004368 WO2003093344A1 (en) 2002-05-03 2003-04-24 Polymeric microemulsions

Publications (1)

Publication Number Publication Date
BR0309688A true BR0309688A (pt) 2005-02-22

Family

ID=29401581

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309688-2A BR0309688A (pt) 2002-05-03 2003-04-24 Microemulsões poliméricas

Country Status (22)

Country Link
US (3) US20060034797A1 (pt)
EP (1) EP1504047B1 (pt)
JP (1) JP4300184B2 (pt)
KR (1) KR20040111466A (pt)
CN (1) CN1290893C (pt)
AR (1) AR039522A1 (pt)
AT (1) ATE380834T1 (pt)
AU (1) AU2003222310B2 (pt)
BR (1) BR0309688A (pt)
CA (1) CA2483282C (pt)
DE (1) DE60318035T2 (pt)
EA (1) EA008244B1 (pt)
ES (1) ES2298510T3 (pt)
IL (1) IL164977A (pt)
MX (1) MXPA04010778A (pt)
MY (1) MY139066A (pt)
NO (1) NO20045283L (pt)
NZ (1) NZ536294A (pt)
PL (1) PL220850B1 (pt)
TW (1) TWI310388B (pt)
WO (1) WO2003093344A1 (pt)
ZA (1) ZA200408854B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
BR0313545B1 (pt) * 2002-08-09 2021-07-27 Janssen Pharmaceutica Nv processos para a preparação de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrila
JP4266926B2 (ja) * 2002-10-21 2009-05-27 ロレアル 両親媒性ブロックコポリマーを用いた水溶液に脂質親和性化合物を溶解させる方法、及び化粧品用組成物
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
JP4929567B2 (ja) * 2004-08-05 2012-05-09 コニカミノルタエムジー株式会社 ポリマーミセル含有製剤の製造方法
NZ553804A (en) * 2004-09-29 2010-07-30 Bayer Schering Pharma Ag Thermodynamically stable form of bay 43-9006 tosylate
WO2006042215A1 (en) * 2004-10-08 2006-04-20 Janssen Pharmaceutica, N.V. 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
EP1922310A2 (en) 2005-09-07 2008-05-21 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as axl inhibitors
JP4892264B2 (ja) * 2006-03-30 2012-03-07 高田製薬株式会社 リスペリドン水性液剤
JPWO2007136134A1 (ja) * 2006-05-23 2009-10-01 ナノキャリア株式会社 疎水性薬物内包ポリマーミセルの製造方法
KR100795214B1 (ko) * 2006-08-22 2008-01-21 이화여자대학교 산학협력단 온도 민감성 졸-젤 전이 폴리(에틸렌글리콜)/폴리(카보네이트) 블록 공중합체 및 이의 제조방법
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
EP2081902A1 (en) * 2006-11-09 2009-07-29 Bayer Schering Pharma Aktiengesellschaft Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
CA2669158A1 (en) * 2006-11-14 2008-05-22 Bayer Schering Pharma Aktiengesellschaft Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
US8012965B2 (en) 2006-12-29 2011-09-06 Rigel Pharmaceuticals, Inc. Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
PT2078010E (pt) 2006-12-29 2014-05-07 Rigel Pharmaceuticals Inc Triazoles substituídos com heteroarilos policíclicos úteis como inibidores de axl
CN101622248B (zh) 2006-12-29 2013-04-17 里格尔制药公司 用作axl抑制剂的n3-杂芳基取代的三唑和n5-杂芳基取代的三唑
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌインヒビターとして有用な置換トリアゾール
US7872000B2 (en) 2006-12-29 2011-01-18 Rigel Pharmaceuticals, Inc. Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
JP5501224B2 (ja) * 2007-05-25 2014-05-21 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 治療薬の経口投与のための製剤および関連する方法
FR2919296A1 (fr) * 2007-07-25 2009-01-30 Rhodia Operations Sas Ouverture de cycles epoxy par des carbenes.
SI2205592T1 (sl) 2007-10-26 2013-09-30 Rigel Pharmaceuticals, Inc. Triazoli substituirani s policikličnim arilom in triazoli substituirani s policikličnim heteroarilom uporabni kot Axl inhibitorji
US8349838B2 (en) 2008-07-09 2013-01-08 Rigel Pharmaceuticals, Inc. Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
JP5613156B2 (ja) 2008-07-09 2014-10-22 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌ阻害剤として有用な架橋二環ヘテロアリール置換トリアゾール
SG172398A1 (en) 2008-12-24 2011-07-28 Tibotec Pharm Ltd Implantable devices for treating hiv
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (zh) * 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 含有伏立康唑的药物制剂及其制备方法
AU2010204578B2 (en) 2009-01-16 2016-05-12 Rigel Pharmaceuticals, Inc. AXL inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
CN101531756B (zh) * 2009-04-16 2011-06-15 山东大学 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
ES2742525T3 (es) 2009-10-01 2020-02-14 Adare Pharmaceuticals Us L P Composiciones de corticosteroides administradas oralmente
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
US9023897B2 (en) * 2010-12-29 2015-05-05 Medincell Biodegradable drug delivery compositions
EP2634179A1 (en) * 2012-02-28 2013-09-04 Sanofi Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging
ITTO20130431A1 (it) * 2013-05-28 2014-11-29 Fond Istituto Italiano Di Tecnologia Copolimero e nanoparticelle da esso ottenute per la veicolazione di un farmaco
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104523592B (zh) * 2015-01-26 2017-03-15 湖北工业大学 甲泼尼龙醋酸酯注射用自微乳制剂及其制备方法
AU2016355236C1 (en) 2015-11-16 2022-09-22 Medincell A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP4137323A1 (en) 2021-08-18 2023-02-22 Imertech Hydraulic binder with low carbon footprint and high early strength

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3779838T2 (de) * 1986-09-05 1992-12-24 American Cyanamid Co Beschichtung fuer chirurgische faeden.
US4716203A (en) * 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
DE3786309T2 (de) * 1986-09-05 1994-02-10 American Cyanamid Co Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme.
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4219536A1 (de) * 1992-06-15 1993-12-16 Herbertz Heinz Verfahren und Zentrifuge zum Entwaessern in Postenwaschanlagen
JP3220331B2 (ja) * 1993-07-20 2001-10-22 エチコン・インコーポレーテツド 非経口投与用の吸収性液体コポリマー類
AU706434B2 (en) * 1994-10-18 1999-06-17 Ethicon Inc. Injectable liquid copolymers for soft tissue repair and augmentation
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5518774A (en) * 1995-06-26 1996-05-21 Olin Corporation In-can and dry coating antimicrobial
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
ATE302599T1 (de) * 1996-05-24 2005-09-15 Angiotech Pharm Inc Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
WO1998035631A1 (en) * 1997-02-14 1998-08-20 Pathak Chandrashekar Biocompatible polymers and methods for their use
US6211249B1 (en) * 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
IL122933A (en) * 1998-01-14 2005-03-20 Efrat Biopolymers Ltd Polymeric carrier for delivery of a bioactive molecule
NZ511116A (en) * 1998-11-10 2003-08-29 Janssen Pharmaceutica Nv HIV replication inhibiting pyrimidines
KR100288103B1 (ko) * 1998-12-26 2001-05-02 윤덕용 폴리에테르가 그라프트된 생분해성 지방족 폴리에스테르 및 그의 제조방법
NZ525726A (en) * 2000-11-09 2004-10-29 Astrazeneca Ab Oral pharmaceutical composition containing a block copolymer
US6617995B2 (en) * 2001-09-24 2003-09-09 Microline Co., Ltd. Radar detector
ATE326679T1 (de) * 2002-01-10 2006-06-15 Davey Bickford Pyrotechnischer elektrischer anzünder und montageverfahren

Also Published As

Publication number Publication date
PL220850B1 (pl) 2016-01-29
EP1504047B1 (en) 2007-12-12
IL164977A0 (en) 2005-12-18
JP4300184B2 (ja) 2009-07-22
KR20040111466A (ko) 2004-12-31
EA008244B1 (ru) 2007-04-27
NZ536294A (en) 2005-05-27
US20110112115A1 (en) 2011-05-12
NO20045283L (no) 2005-01-07
AU2003222310B2 (en) 2009-04-09
JP2005524730A (ja) 2005-08-18
ZA200408854B (en) 2005-11-02
IL164977A (en) 2007-12-03
MY139066A (en) 2009-08-28
CN1290893C (zh) 2006-12-20
US20060034797A1 (en) 2006-02-16
AR039522A1 (es) 2005-02-23
CA2483282A1 (en) 2003-11-13
DE60318035T2 (de) 2008-12-11
CA2483282C (en) 2012-05-29
EP1504047A1 (en) 2005-02-09
TWI310388B (en) 2009-06-01
MXPA04010778A (es) 2005-03-07
TW200413434A (en) 2004-08-01
ES2298510T3 (es) 2008-05-16
AU2003222310A1 (en) 2003-11-17
ATE380834T1 (de) 2007-12-15
EA200401465A1 (ru) 2005-04-28
PL371934A1 (en) 2005-07-11
WO2003093344A1 (en) 2003-11-13
CN1649932A (zh) 2005-08-03
US20150086504A1 (en) 2015-03-26
DE60318035D1 (de) 2008-01-24

Similar Documents

Publication Publication Date Title
BR0309688A (pt) Microemulsões poliméricas
BR0106661A (pt) Utilização de copolìmeros etilênicos sequenciados com caráter elástico e composição cosmética
ATE478120T1 (de) Thermoplastische zusammensetzungen
BRPI0714417B8 (pt) método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico
NO20043913L (no) Blandinger med modifisert frigjoring av i det minste en form av tramadol
YU67202A (sh) Farmaceutski preparati inhibitora glikogen fosforilaze
DE60222931D1 (de) Pyrazolopyrimidinonderivate mit pde7-hemmender wirkung
BR0212922A (pt) Composições farmacêuticas
RS51563B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ROOSUVASTATIN CALCIUM
BR0214577A (pt) Copolìmero de etileno/alfa-olefina feito com uma combinação de um catalisador de sìtio-único/sìtio-não-único, sua preparação e uso
BRPI0512326A (pt) composições compreendendo anfotericina b, métodos e sistemas
ATE554152T1 (de) Zusammensetzung, die ein gel bilden kann, umfassend ein copolymer, und verwendbare copolymere
BR0317392A (pt) Formulação não-higroscópica incluindo uma droga higroscópica
BRPI0505630A (pt) transferência de mìdia digital baseada no comportamento do usuário
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
WO2008018045A3 (en) Personal care composition
WO2004014926A8 (fr) Alcoxyamines issues de nitroxydes βετα-phosphores, leur utilisation en polymerisation radicalaire
PH12014501403A1 (en) Herbicidal composition
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
BRPI0411528A (pt) uso de isomalte como prebiótico
EP1418187A3 (en) Alkyl (meth) acrylate copolymers
EP1431363A3 (en) Hot melt adhesive based on acrylic block copolymers
DK1965655T3 (da) Tyggegummi og gummibase omfattende styren-isopren-styren-copolymerer
GB0123572D0 (en) Polymer compositions
ATE446335T1 (de) Antiblockmittel mit vernetzbarem silicon- enthaltenden polyolefin

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.